Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:

★Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

★Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

★Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

★Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

1 Market Overview
1.1 Tumor-on-a-chip Product Introduction
1.2 Global Tumor-on-a-chip Market Size Forecast
1.3 Tumor-on-a-chip Market Trends & Drivers
1.3.1 Tumor-on-a-chip Industry Trends
1.3.2 Tumor-on-a-chip Market Drivers & Opportunity
1.3.3 Tumor-on-a-chip Market Challenges
1.3.4 Tumor-on-a-chip Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Tumor-on-a-chip Players Revenue Ranking (2023)
2.2 Global Tumor-on-a-chip Revenue by Company (2019-2024)
2.3 Key Companies Tumor-on-a-chip Manufacturing Base Distribution and Headquarters
2.4 Key Companies Tumor-on-a-chip Product Offered
2.5 Key Companies Time to Begin Mass Production of Tumor-on-a-chip
2.6 Tumor-on-a-chip Market Competitive Analysis
2.6.1 Tumor-on-a-chip Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Tumor-on-a-chip Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor-on-a-chip as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PDX Model
3.1.2 CDX Model
3.2 Global Tumor-on-a-chip Sales Value by Type
3.2.1 Global Tumor-on-a-chip Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Tumor-on-a-chip Sales Value, by Type (2019-2030)
3.2.3 Global Tumor-on-a-chip Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical & Biotechnology Companies
4.1.2 Academic & Research Institutes
4.1.3 Others
4.2 Global Tumor-on-a-chip Sales Value by Application
4.2.1 Global Tumor-on-a-chip Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Tumor-on-a-chip Sales Value, by Application (2019-2030)
4.2.3 Global Tumor-on-a-chip Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Tumor-on-a-chip Sales Value by Region
5.1.1 Global Tumor-on-a-chip Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Tumor-on-a-chip Sales Value by Region (2019-2024)
5.1.3 Global Tumor-on-a-chip Sales Value by Region (2025-2030)
5.1.4 Global Tumor-on-a-chip Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Tumor-on-a-chip Sales Value, 2019-2030
5.2.2 North America Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Tumor-on-a-chip Sales Value, 2019-2030
5.3.2 Europe Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Tumor-on-a-chip Sales Value, 2019-2030
5.4.2 Asia Pacific Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Tumor-on-a-chip Sales Value, 2019-2030
5.5.2 South America Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Tumor-on-a-chip Sales Value, 2019-2030
5.6.2 Middle East & Africa Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Tumor-on-a-chip Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Tumor-on-a-chip Sales Value
6.3 United States
6.3.1 United States Tumor-on-a-chip Sales Value, 2019-2030
6.3.2 United States Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Tumor-on-a-chip Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Tumor-on-a-chip Sales Value, 2019-2030
6.4.2 Europe Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Tumor-on-a-chip Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Tumor-on-a-chip Sales Value, 2019-2030
6.5.2 China Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
6.5.3 China Tumor-on-a-chip Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Tumor-on-a-chip Sales Value, 2019-2030
6.6.2 Japan Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Tumor-on-a-chip Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Tumor-on-a-chip Sales Value, 2019-2030
6.7.2 South Korea Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Tumor-on-a-chip Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Tumor-on-a-chip Sales Value, 2019-2030
6.8.2 Southeast Asia Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Tumor-on-a-chip Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Tumor-on-a-chip Sales Value, 2019-2030
6.9.2 India Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
6.9.3 India Tumor-on-a-chip Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cellesce
7.1.1 Cellesce Profile
7.1.2 Cellesce Main Business
7.1.3 Cellesce Tumor-on-a-chip Products, Services and Solutions
7.1.4 Cellesce Tumor-on-a-chip Revenue (US$ Million) & (2019-2024)
7.1.5 Cellesce Recent Developments
7.2 Daxiang Biotech
7.2.1 Daxiang Biotech Profile
7.2.2 Daxiang Biotech Main Business
7.2.3 Daxiang Biotech Tumor-on-a-chip Products, Services and Solutions
7.2.4 Daxiang Biotech Tumor-on-a-chip Revenue (US$ Million) & (2019-2024)
7.2.5 Daxiang Biotech Recent Developments
7.3 Mimetas
7.3.1 Mimetas Profile
7.3.2 Mimetas Main Business
7.3.3 Mimetas Tumor-on-a-chip Products, Services and Solutions
7.3.4 Mimetas Tumor-on-a-chip Revenue (US$ Million) & (2019-2024)
7.3.5 InSphero Recent Developments
7.4 InSphero
7.4.1 InSphero Profile
7.4.2 InSphero Main Business
7.4.3 InSphero Tumor-on-a-chip Products, Services and Solutions
7.4.4 InSphero Tumor-on-a-chip Revenue (US$ Million) & (2019-2024)
7.4.5 InSphero Recent Developments
7.5 Hepregen
7.5.1 Hepregen Profile
7.5.2 Hepregen Main Business
7.5.3 Hepregen Tumor-on-a-chip Products, Services and Solutions
7.5.4 Hepregen Tumor-on-a-chip Revenue (US$ Million) & (2019-2024)
7.5.5 Hepregen Recent Developments
7.6 Charles River
7.6.1 Charles River Profile
7.6.2 Charles River Main Business
7.6.3 Charles River Tumor-on-a-chip Products, Services and Solutions
7.6.4 Charles River Tumor-on-a-chip Revenue (US$ Million) & (2019-2024)
7.6.5 Charles River Recent Developments
8 Industry Chain Analysis
8.1 Tumor-on-a-chip Industrial Chain
8.2 Tumor-on-a-chip Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Tumor-on-a-chip Sales Model
8.5.2 Sales Channel
8.5.3 Tumor-on-a-chip Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Tumor-on-a-chip Market Trends
Table 2. Tumor-on-a-chip Market Drivers & Opportunity
Table 3. Tumor-on-a-chip Market Challenges
Table 4. Tumor-on-a-chip Market Restraints
Table 5. Global Tumor-on-a-chip Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Tumor-on-a-chip Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Tumor-on-a-chip Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Tumor-on-a-chip Product Type
Table 9. Key Companies Time to Begin Mass Production of Tumor-on-a-chip
Table 10. Global Tumor-on-a-chip Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor-on-a-chip as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Tumor-on-a-chip Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Tumor-on-a-chip Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Tumor-on-a-chip Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Tumor-on-a-chip Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Tumor-on-a-chip Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Tumor-on-a-chip Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Tumor-on-a-chip Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Tumor-on-a-chip Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Tumor-on-a-chip Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Tumor-on-a-chip Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Tumor-on-a-chip Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Tumor-on-a-chip Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Tumor-on-a-chip Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Tumor-on-a-chip Sales Value by Region (2019-2024) & (%)
Table 27. Global Tumor-on-a-chip Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Tumor-on-a-chip Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Tumor-on-a-chip Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Tumor-on-a-chip Sales Value, (2025-2030) & (US$ Million)
Table 31. Cellesce Basic Information List
Table 32. Cellesce Description and Business Overview
Table 33. Cellesce Tumor-on-a-chip Products, Services and Solutions
Table 34. Revenue (US$ Million) in Tumor-on-a-chip Business of Cellesce (2019-2024)
Table 35. Cellesce Recent Developments
Table 36. Daxiang Biotech Basic Information List
Table 37. Daxiang Biotech Description and Business Overview
Table 38. Daxiang Biotech Tumor-on-a-chip Products, Services and Solutions
Table 39. Revenue (US$ Million) in Tumor-on-a-chip Business of Daxiang Biotech (2019-2024)
Table 40. Daxiang Biotech Recent Developments
Table 41. Mimetas Basic Information List
Table 42. Mimetas Description and Business Overview
Table 43. Mimetas Tumor-on-a-chip Products, Services and Solutions
Table 44. Revenue (US$ Million) in Tumor-on-a-chip Business of Mimetas (2019-2024)
Table 45. Mimetas Recent Developments
Table 46. InSphero Basic Information List
Table 47. InSphero Description and Business Overview
Table 48. InSphero Tumor-on-a-chip Products, Services and Solutions
Table 49. Revenue (US$ Million) in Tumor-on-a-chip Business of InSphero (2019-2024)
Table 50. InSphero Recent Developments
Table 51. Hepregen Basic Information List
Table 52. Hepregen Description and Business Overview
Table 53. Hepregen Tumor-on-a-chip Products, Services and Solutions
Table 54. Revenue (US$ Million) in Tumor-on-a-chip Business of Hepregen (2019-2024)
Table 55. Hepregen Recent Developments
Table 56. Charles River Basic Information List
Table 57. Charles River Description and Business Overview
Table 58. Charles River Tumor-on-a-chip Products, Services and Solutions
Table 59. Revenue (US$ Million) in Tumor-on-a-chip Business of Charles River (2019-2024)
Table 60. Charles River Recent Developments
Table 61. Key Raw Materials Lists
Table 62. Raw Materials Key Suppliers Lists
Table 63. Tumor-on-a-chip Downstream Customers
Table 64. Tumor-on-a-chip Distributors List
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
Table 68. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Tumor-on-a-chip Product Picture
Figure 2. Global Tumor-on-a-chip Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Tumor-on-a-chip Sales Value (2019-2030) & (US$ Million)
Figure 4. Tumor-on-a-chip Report Years Considered
Figure 5. Global Tumor-on-a-chip Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Tumor-on-a-chip Revenue in 2023
Figure 7. Tumor-on-a-chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. PDX Model Picture
Figure 9. CDX Model Picture
Figure 10. Global Tumor-on-a-chip Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Tumor-on-a-chip Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Pharmaceutical & Biotechnology Companies
Figure 13. Product Picture of Academic & Research Institutes
Figure 14. Product Picture of Others
Figure 15. Global Tumor-on-a-chip Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Tumor-on-a-chip Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Tumor-on-a-chip Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Tumor-on-a-chip Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Tumor-on-a-chip Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Tumor-on-a-chip Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Tumor-on-a-chip Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Tumor-on-a-chip Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Tumor-on-a-chip Sales Value (%), (2019-2030)
Figure 28. United States Tumor-on-a-chip Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Tumor-on-a-chip Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Tumor-on-a-chip Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Tumor-on-a-chip Sales Value by Application (%), 2023 VS 2030
Figure 34. China Tumor-on-a-chip Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
Figure 36. China Tumor-on-a-chip Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Tumor-on-a-chip Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Tumor-on-a-chip Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Tumor-on-a-chip Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Tumor-on-a-chip Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Tumor-on-a-chip Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Tumor-on-a-chip Sales Value by Application (%), 2023 VS 2030
Figure 46. India Tumor-on-a-chip Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Tumor-on-a-chip Sales Value by Type (%), 2023 VS 2030
Figure 48. India Tumor-on-a-chip Sales Value by Application (%), 2023 VS 2030
Figure 49. Tumor-on-a-chip Industrial Chain
Figure 50. Tumor-on-a-chip Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation